Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 24;6(5):820-828.
doi: 10.1021/acsptsci.3c00038. eCollection 2023 May 12.

Exosomal MicroRNA-223, MicroRNA-146, and MicroRNA-21 Profiles and Biochemical Changes in Laryngeal Cancer

Affiliations

Exosomal MicroRNA-223, MicroRNA-146, and MicroRNA-21 Profiles and Biochemical Changes in Laryngeal Cancer

Sidika Genc et al. ACS Pharmacol Transl Sci. .

Abstract

Laryngeal squamous cell carcinoma (LSCC) is one of the most aggressive cancers, and its early diagnosis is urgent. Exosomes are believed to have diagnostic significance in cancer. However, the role of serum exosomal microRNAs, miR-223, miR-146, and miR-21, and phosphatase and tensin homologue (PTEN) and hemoglobin subunit delta (HBD) mRNAs in LSCC is unclear. Exosomes were isolated from the blood serum of 10 LSCC patients and 10 healthy controls to perform scanning electron microscopy and liquid chromatography quadrupole time-of-flight mass spectrometry analyses to characterize them and to undergo reverse transcription polymerase chain reaction to identify miR-223, miR-146, miR-21, and PTEN and HBD mRNA expression phenotypes. Biochemical parameters, including serum C-reactive protein (CRP) and vitamin B12, were also obtained. Serum exosomes of 10-140 nm were isolated from LSCC and controls. Serum exosomal miR-223, miR-146, and PTEN were found to be significantly decreased (p < 0.05), in contrast to serum exosomal miRNA-21 (p < 0.01), and serum vitamin B12 and CRP (p < 0.05) were found to be significantly increased, in LSCC vs controls. Our novel data show that the combination of reduced serum exosomal miR-223, miR-146, and miR-21 profiles and biochemical alterations in CRP and vitamin B12 levels may be useful indicators of LSCC that could be validated by large studies. Our findings also suggest a possible negative regulatory effect of miR-21 on PTEN in LSCC, encouraging a more extensive investigation of its role.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Representative MRI findings in the right section of the neck. Diagnosis; laryngeal tumor. White arrows show the larynx cancer area, orange arrows show the vertebra, and yellow arrows show the larynx.
Figure 2
Figure 2
Representative pathological image of a patient with LSCC diagnosis showing invasiveness, heterogeneity, and amorphous cell formation (100 μm hematoxylin and eosin staining; by ImageScope). Red arrow: infiltrative cancer cells.
Figure 3
Figure 3
Controls (A) and LSCC (B) patient serum exosomes examined by SEM. The white arrow shows particle size. P: particle, Pa: particle size in nm, Pb: particle angle and, Pa R: particle radius. (by Carl Zeiss Evo 40 SEM; Jena Germany).
Figure 4
Figure 4
Diagram depicts the total results from QTOF analysis (A). Diagrams (B) depict the QTOF of each molecule: (a) nummularine, (b) N-caffeoyltryptophan, (c) 1-monopalmitin, (d) hexadecyl acetyl glycerol, (e) pipericine, and (f) cyclohexanecarbonylpentadecylamine (Agilent 6530 QTOF).
Figure 5
Figure 5
Serum exosomal miRNA-223, miRNA-146, and miRNA-21 levels (A), and PTEN and HBD mRNA levels (B) in serum LSCC and healthy controls (*p < 0.05; **p < 0.001; by t-test; GraphPad Prism 7.0). (miRNA levels were normalized to the RNU6 reference control; mRNA levels were normalized to the β-actin reference gene).

Similar articles

Cited by

References

    1. Bray F.; Ferlay J.; Soerjomataram I.; Siegel R. L.; Torre L. A.; Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J. Clin. 2018, 68, 394–424. 10.3322/caac.21492. - DOI - PubMed
    1. Rubinstein M.; Armstrong W. b. Transoral laser microsurgery for laryngeal cancer: a primer and review of laser dosimetry. Lasers Med. Sci. 2011, 26, 113–124. 10.1007/s10103-010-0834-5. - DOI - PMC - PubMed
    1. Gao X.; Fisher S. G.; Mohideen N.; Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int. J. Radiat. Oncol., Biol., Phys. 2003, 56, 427–435. 10.1016/s0360-3016(02)04613-8. - DOI - PubMed
    1. Sethi N.; Wright A.; Wood H.; Rabbitts P. MicroRNAs and head and neck cancer: reviewing the first decade of research. Eur. J. Cancer 2014, 50, 2619–2635. 10.1016/j.ejca.2014.07.012. - DOI - PubMed
    1. Vageli D. P.; Doukas S. G.; Doukas P. G.; Judson B. L. Bile reflux and hypopharyngeal cancer (Review). Oncol. Rep. 2021, 46, 244.10.3892/or.2021.8195. - DOI - PMC - PubMed

LinkOut - more resources